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Several models for estimating risk of incident diabetes in US adults are available. The authors aimed to de-
termine the discriminative ability and calibration of published diabetes risk prediction models in a contemporary
multiethnic cohort. Participants in the Multi-Ethnic Study of Atherosclerosis without diabetes at baseline (2000–
2002; n ¼ 5,329) were followed for a median of 4.75 years. The predicted risk of diabetes was calculated using
published models from the Framingham Offspring Study, the Atherosclerosis Risk in Communities (ARIC) Study,
and the San Antonio Heart Study. The mean age of participants was 61.6 years (standard deviation, 10.2); 29.3%
were obese, 53.1% had hypertension, 34.9% had a family history of diabetes, 27.5% had high triglyceride levels,
33.8% had low high density lipoprotein cholesterol levels, and 15.3% had impaired fasting glucose. There were 446
incident cases of diabetes (fasting glucose level 126 mg/dL or initiation of antidiabetes medication use) diag-
nosed during follow-up. C statistics were 0.78, 0.84, and 0.83 for the Framingham, ARIC, and San Antonio risk
prediction models, respectively. There were significant differences between observed and predicted diabetes risks
(Hosmer-Lemeshow goodness-of-fit chi-squared test for each model: P < 0.001). The recalibrated and best-fit
models achieved sufficient goodness of fit (each P > 0.10). The Framingham, ARIC, and San Antonio models
maintained high discriminative ability but required recalibration in a modern, multiethnic US cohort.
cohort studies; diabetes mellitus; models, statistical; risk; validation studies as topic
Abbreviations: ARIC, Atherosclerosis Risk in Communities; CI, confidence interval; HDL, high density lipoprotein; MESA, Multi-
Ethnic Study of Atherosclerosis.
The prevalence (1) and incidence (2) of diabetes mellitus
are increasing at alarming rates in the United States and
worldwide. The identification of adults at high risk for in-
cident diabetes is important for implementing interventions
in a cost-effective manner (3, 4). Clinicians use many risk
factors, such as obesity, family history, hypertension, the
metabolic syndrome, and impaired fasting glucose, to gauge
a patient’s risk for the development of diabetes.
Several equations for predicting incident diabetes
among US and international populations have been devel-
oped (5–9). Using a variety of risk factors and weighting
schemes, these equations have demonstrated strong test
characteristics. However, these equations were developed
in ethnically and geographically limited populations. For
example, the Framingham Offspring Study included pri-
marily whites, the Atherosclerosis Risk in Communities
(ARIC) Study included whites and African Americans,
and the San Antonio Heart Study was limited to whites
and Mexican Americans. In addition, these cohort studies
were initiated over 20 years ago, and their data may not
reflect the latest trends in the diabetes epidemic. Further-
more, these equations have not been externally validated.
The ability of a risk prediction model to identify persons at
high risk for diabetes (i.e., discrimination) in a multiethnic
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population is important, as there are substantial disparities
in diabetes risk by ethnicity (10). Additionally, calibration
provides important information beyond discrimination,
since it assesses the accuracy of the predicted risks as
compared with observed risks (11). As has been seen for
the Framingham coronary heart disease risk scoring sys-
tem, there can be significant over- or underestimation of
events when the equations are applied to diverse popula-
tions without appropriate calibration (12, 13).
Our objective in this analysis was to determine the dis-
criminative ability and calibration of 3 published diabetes
risk prediction models derived from single (Framingham) or
biethnic (ARIC, San Antonio) US populations in a contem-
porary, multiethnic population of US adults. To do so, we
analyzed longitudinal data on the incidence of diabetes from
the Multi-Ethnic Study of Atherosclerosis (MESA).
MATERIALS AND METHODS
Study population
Details regarding the design and objectives of MESA have
been published previously (14). In brief, 6,814 white,
African-American, Hispanic, and Chinese-American partici-
pants aged 45–84 years with no evidence of clinical cardio-
vascular disease were recruited from 6 geographically diverse
US communities (Baltimore, Maryland; Chicago, Illinois;
Forsyth County, North Carolina; Los Angeles, California;
New York, New York; and St. Paul, Minnesota). Participants
with atrial fibrillation, active cancer, cognitive impairment, or
weight greater than 300 pounds (136 kg) and those who were
pregnant were excluded. Among the 6,814MESA participants
enrolled, 859 had diabetes (fasting glucose level126 mg/dL
or use of hypoglycemic medication or insulin) at baseline
and 626 were missing information needed to calculate their
diabetes risk. After these exclusions, 5,329 participants were
included in the current analyses.
Data collection
Data were collected during a baseline examination
(2000–2002) and at 3 follow-up visits (MESA examinations
2, 3, and 4) occurring at 18-month intervals. During the
baseline examination, standardized questionnaires were uti-
lized to obtain data on demographic factors, tobacco use,
medical conditions, and currently prescribed medications.
Body weight, height, and waist circumference were mea-
sured by trained study staff. At baseline, height and weight
were measured with participants wearing light clothing and
no shoes. An Accu-Hite stadiometer (Seca GmbH & Com-
pany KG, Hamburg, Germany) was used to measure height,
and a Detecto platform balance scale (Titus Home Health
Care, Alhambra, California) was used to measure weight.
Body mass index was calculated as weight (kg) divided by
height (m) squared; overweight was defined as body mass
index 25 and obesity as body mass index 30. Waist
circumference was measured using a Gulick II anthropomet-
ric tape (Sammons Preston, Chicago, Illinois) applied hor-
izontally at the level of the umbilicus and was rounded to the
nearest centimeter. Family history of diabetes (parent or
sibling) was not assessed at baseline but was assessed at
examination 2, and this response was used for analysis.
Resting seated blood pressure was measured 3 times us-
ing an automated oscillometric sphygmomanometer (Dina-
map PRO 100; Critikon, Tampa Bay, Florida); the last 2
measurements were averaged for analysis. Elevated blood
pressure was defined as systolic blood pressure 130 mm
Hg or diastolic blood pressure 85 mm Hg or use of anti-
hypertensive medication. Participants were asked to fast
overnight prior to their examination. Fasting blood glucose
and lipid levels were analyzed at a central laboratory. Serum
glucose level was measured using a Vitros analyzer
(Johnson & Johnson Clinical Diagnostics, Rochester, New
York). Among participants who were not using hypoglyce-
mic drugs or insulin, impaired fasting glucose was defined
as a glucose level of 100–125 mg/dL. Plasma lipids, includ-
ing high density lipoprotein (HDL) cholesterol and triglyc-
erides, were measured using a standardized kit (Roche
Diagnostics Corporation, Indianapolis, Indiana). Low
HDL cholesterol levels were defined as <40 mg/dL for
men or <50 mg/dL for women, and high triglyceride levels
were defined as 150 mg/dL. Metabolic syndrome was de-
fined according to the revised National Cholesterol Education
Program Adult Treatment Panel III criteria (15). The individ-
ual components of the metabolic syndrome include waist
circumference >88 cm for women or >102 cm for men,
serum glucose level 110 mg/dL, systolic/diastolic blood
pressure 130/85 mm Hg or use of antihypertensive medi-
cation, HDL cholesterol level <40 mg/dL for men or <50
mg/dL for women, and triglyceride level 150 mg/dL. Par-
ticipants with 3 or more of these components were catego-
rized as having metabolic syndrome.
Risk prediction models
The primary exposures of interest included equations for
predicting incident diabetes derived in the Framingham Off-
spring Study, the ARIC Study, and the San Antonio Heart
Study (see Appendix). The baseline visits used for develop-
ing these models were conducted in 1971–1975 for the
Framingham Offspring Study, 1987–1989 for the ARIC
Study, and 1979–1988 for the San Antonio Heart Study,
and diabetes incidence in these studies was determined over
periods of 8, 9, and 7.5 years, respectively. Details on each
of these cohort studies and the development of their diabetes
risk prediction equations are available elsewhere (5–7).
In brief, the Framingham diabetes risk prediction model
includes overweight and obesity, impaired fasting glucose,
low HDL cholesterol, high triglycerides, elevated blood
pressure, and parental history of diabetes. This model uses
a point scoring algorithm with the risk of incident diabetes
being correlated with a person’s overall point score. The
diabetes risk prediction model derived in the ARIC Study
includes height, waist circumference, black race/ethnicity,
systolic blood pressure, fasting glucose, HDL cholesterol,
triglycerides, and a parental history of diabetes. The San
Antonio diabetes risk prediction model includes age, sex,
Mexican-American ethnicity, fasting glucose, systolic blood
pressure, HDL cholesterol, body mass index, and family
history of diabetes (parent or sibling). MESA included
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a broader population with respect to age and race/ethnicity.
If a participant’s race/ethnicity was not included in the equa-
tion being evaluated, it was coded as the referent value. For
example, a Chinese-American participant in MESA was
coded as not Hispanic in the San Antonio model and not
African-American in the ARIC model. Similarly, the ages of
MESA participants were used in the San Antonio and ARIC
models even if their ages were outside the range of partic-
ipants included in those studies (age is not a component of
the Framingham model). Since MESA did not assess Latino
subgroups, we coded all Latinos from MESA as Mexican-
American when applying the San Antonio model. For the
ARIC and San Antonio diabetes risk prediction models,
these variables are incorporated into a logistic regression
model used to calculate the probability of developing
diabetes.
Study outcome
The outcome for the current study was the incidence of
diabetes. Incident diabetes was determined using data col-
lected during 3 in-person MESA follow-up examinations.
The incidence of diabetes was defined as the first visit at
which a MESA participant self-reported use of oral hypo-
glycemic drugs or insulin or had a fasting serum glucose
level greater than or equal to 126 mg/dL.
Statistical analysis
The mean level and prevalence of each component of
each diabetes risk model was calculated overall and by eth-
nicity. The probability of developing diabetes over a period
of 4.75 years (the median duration of follow-up of partici-
pants in this analysis) was determined for the overall study
population and for participants with and without individual
components of each risk prediction model, using interval-
censored regression models (16). The distributions of the
predicted probabilities of diabetes for the Framingham Off-
spring Study, ARIC Study, and San Antonio Heart Study
risk equations were calculated. Since MESA provided a me-
dian of 4.75 years of follow-up, the predicted probability for
each diabetes risk prediction equation was estimated for this
Table 1. Mean Levels and Prevalences of Diabetes Risk Factors Among ParticipantsWithout Diabetes at Baseline (2000–2002), Overall and By
Race/Ethnicity, Multi-Ethnic Study of Atherosclerosis
Characteristic






Mean (SD) % Mean (SD) % Mean (SD) % Mean (SD) % Mean (SD) %
Age, years 61.6 (10.2) 62.3 (10.2) 61.4 (10.2) 60.5 (10.3) 60.9 (10.2)
Male sex 46.7 47.6 44.1 47.2 48.1
Body mass indexa 28.0 (5.3) 27.5 (4.9) 29.8 (5.8) 29.0 (4.9) 23.9 (3.3)
25–29 40.3 41.1 38.6 46.3 29.8
30 29.3 25.4 42.1 35.3 4.4
Waist circumference, cm 97.0 97.1 86.6 99.7 99.4
Abdominal obesityb 51.4 51.0 22.6 59.2 58.7
Systolic blood pressure,
mm Hg
125.1 (20.9) 122.6 (20.0) 130.6 (21.2) 125.2 (21.2) 122.5 (21.0)
Diastolic blood pressure,
mm Hg
71.8 (10.2) 70.1 (9.9) 74.6 (10.0) 71.8 (10.1) 71.9 (10.3)
Antihypertensive treatment 33.0 30.7 44.8 28.0 24.6
Elevated blood pressurec 53.1 49.9 66.0 48.5 45.4
Parental or sibling history
of diabetes
34.9 29.4 42.7 41.5 26.2
Triglyceride level, mg/dL 127.0 (77.5) 129.1 (75.5) 99.1 (54.8) 149.9 (93.8) 138.7 (76.6)
Triglyceride level 150 mg/dL 27.5 29.3 13.0 38.6 32.5
HDL cholesterol level, mg/dL 51.7 (14.9) 52.9 (15.7) 53.3 (15.3) 48.5 (13.4) 50.0 (12.8)
Low HDL cholesterol leveld 33.8 30.7 29.4 43.6 37.1
Fasting glucose level, mg/dL 89.4 (10.5) 87.7 (10.0) 90.1 (10.7) 91.0 (10.8) 91.4 (10.0)
Fasting glucose level
100–125 mg/dL
15.3 11.3 17.4 18.8 19.3
Metabolic syndrome 25.5 25.9 22.4 32.6 18.4
Abbreviations: HDL, high density lipoprotein; SD, standard deviation.
a Weight (kg)/height (m)2.
b Defined as >88 cm for women and >102 cm for men.
c Defined as blood pressure 130/85 mm Hg or antihypertensive treatment.
d Defined as <40 mg/dL for men and <50 mg/dL for women.
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time period. We achieved this by dividing each MESA par-
ticipant’s predicted probability of developing diabetes by
the number of years of follow-up used in each of the prior
studies (e.g., 9 years in the ARIC Study) and multiplying
this number by 4.75 years. This approach assumes that the
risk of diabetes is constant over time. Results were markedly
similar when nonconstant rates of diabetes incidence (i.e.,
logarithmic and exponential rates) were modeled.
The predicted probability of diabetes was divided into
quintiles, and probabilities of and hazard ratios for incident
diabetes were calculated by quintile using interval-censored
regression models. Next, using logistic regression models
with incident diabetes as the outcome, we calculated the c
statistic for each of the diabetes risk prediction models. C
statistics were calculated for the overall MESA population
and for each racial/ethnic group separately. We compared c
statistics for the diabetes risk equations, pairwise, using the
method of DeLong et al. (17) for correlated data. We uti-
lized t tests, using Taylor series approximation to calculate
standard errors, to determine the statistical significance of
differences in c statistics across ethnic groups for each pre-
diction equation. We also calculated c statistics for individ-
ual diabetes risk factors.
To assess calibration of the risk prediction equations, we
calculated the observed and predicted incidence rates of
diabetes by quintile of predicted risk for each equation
and compared them using the Hosmer-Lemeshow goodness-
of-fit chi-squared test (18). Next, we calculated the
predicted risk of diabetes after recalibrating each equation
using the method described by D’Agostino et al. (13). This
procedure involves replacing the average diabetes incidence
rate from each cohort (i.e., the intercept) with the average
diabetes incidence rate from MESA and replacing the mean
values of risk equation components from each of the prior
studies with the mean values from MESA.
Finally, using the variables in each prediction equation,
we generated best-fit models. The best-fit process produces
predicted values for the incidence of diabetes as close to the
diabetes rates (observed values) as possible. The predicted
risks of diabetes after recalibration and using the best-fit
model, separately, were compared with the observed inci-
dence of diabetes via the Hosmer-Lemeshow goodness-of-
fit chi-squared test. Sensitivity analyses were conducted us-
ing a Framingham model which applies an exponential
function incorporating a linear combination of each of the
variables to estimate the probability of developing diabetes
(see Appendix Table 1). Analyses were conducted using
Stata, version 9 (Stata Corporation, College Station, Texas)
and SAS, version 9.2 (SAS Institute Inc., Cary, North
Carolina).
RESULTS
Characteristics of the MESA participants included in the
current analysis are displayed overall and by race/ethnicity
in Table 1. Overall, the mean age was 61.6 years (standard
deviation, 10.2); 46.7% of the participants were male, and
the racial/ethnic breakdown was 42.6% white, 25.2%
African-American, 11.5% Chinese-American, and 20.7%
Table 2. Probability of Developing Diabetes Over a 4.75-Year
Perioda According to Demographic Factors and Diabetes Risk











Total 446 5,329 8.7
Age, years
<65 262 3,127 8.4
65 184 2,202 9.0
Sex
Male 207 2,489 8.7
Female 239 2,840 8.6
Race/ethnicity
White 137 2,272 6.2
African-American 140 1,341 11.0
Hispanic 124 1,101 11.7
Chinese-American 45 615 7.5
Body mass indexc
<25 58 1,625 3.7
25–29 159 2,145 7.7
30 229 1,559 15.1









No 215 3,470 6.5
Yes 231 1,859 12.8
Smoking status
Never smoker 216 2,692 8.3
Former smoker 179 1,966 9.5




40 (men) or 50
(women)
224 3,529 6.6




<150 268 3,865 7.2
150 178 1,464 12.6
Fasting glucose level,
mg/dL
<100 178 4,512 4.1
100–125 268 817 34.7
Abdominal obesityd
No 125 2,592 5.0
Yes 321 2,737 12.1
Metabolic syndrome
No 213 3,969 4.5
Yes 233 1,360 19.1
a Data were collected during the baseline examination (2000–
2002) and at 3 follow-up visits occurring at 18-month intervals.
b Probability was calculated for 4.75 years of follow-up using
interval-censored methods.
c Weight (kg)/height (m)2.
d Defined as >88 cm for women and >102 cm for men.
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Hispanic. Over the course of 23,995 person-years of follow-
up (median, 4.75 years; interquartile range: 4.5–5.0 years),
446 new cases of diabetes were diagnosed. The probability
of developing diabetes over 4.75 years of follow-up was
8.7% (Table 2). The probability of developing diabetes
was higher among African Americans and Hispanics (vs.
whites and Chinese Americans) and among persons with
a higher body mass index, elevated blood pressure, a family
history of diabetes (parent or sibling), low HDL cholesterol
levels, high triglyceride levels, impaired fasting glucose,
and the metabolic syndrome. The probabilities of and haz-
ard ratios for diabetes incidence increased by quintile of
predicted risk for each equation (Table 3).
Discriminative validity
C statistics for the incidence of diabetes were 0.78 (95%
confidence interval (CI): 0.74, 0.82), 0.84 (95% CI: 0.82,
0.86), and 0.83 (95% CI: 0.81, 0.85) for the Framingham,
ARIC, and San Antonio diabetes risk models, respectively
(Table 4). Discrimination was significantly better for the
ARIC and San Antonio models than for the Framingham
model (P < 0.01 for each pairwise comparison). In sensi-
tivity analyses using a logistic regression equation for the
Framingham model rather than the point scoring
system, the c statistic was 0.81 (95% CI: 0.79, 0.84), which
was not significantly different from the c statistics derived
from the ARIC and San Antonio models (P > 0.05). For
the Framingham and ARIC models, c statistics were
similar for all racial/ethnic groups. However, using the
San Antonio model, the c statistic was significantly lower
among African-American participants than among white
participants.
Discriminatory value of individual risk factors
The risk prediction components, modeled individually,
demonstrated significantly inferior discriminative ability
when compared with the full risk prediction models (each
P < 0.01). For example, the c statistic was 0.74 (95% CI:
0.73, 0.76) for impaired fasting glucose, 0.73 (95% CI: 0.71,
0.75) for metabolic syndrome, 0.69 (95% CI: 0.66, 0.71) for
waist circumference, 0.65 (95% CI: 0.63, 0.67) for body
mass index, and 0.59 (95% CI: 0.56, 0.62) for family history
of diabetes.
Model calibration and best-fit models
The Framingham diabetes risk model underestimated the
risk of diabetes in all quintiles of predicted diabetes risk
(Figure 1 and Appendix Table 2). The ARIC prediction
model underestimated risk of diabetes in the highest quintile
but was accurate in all other quintiles, while the San Antonio
model overestimated diabetes risk in all quintiles. The
Hosmer-Lemeshow goodness-of-fit test result was significant
for each model (P < 0.001). After recalibration, all of the
Table 3. Probabilities and Hazard Ratios for Incident Diabetes in the Multi-Ethnic Study of Atherosclerosis According to Quintile of Predicted
Diabetes Risk, Determined Using Risk Prediction Equations From the Framingham Offspring Study, the Atherosclerosis Risk in Communities




Quintile of Predicted Risk
P-Trend
1 2 3 4 5
Framingham Offspring Studya
Range of scores 0–2 3–5 6–10 11–13 14–28
Range of predicted riskb 4 4 4 5–6 7–44
Probabilityc, % 3.3 3.3 3.3 6.7 28.9 <0.001
HR (95% CI) 1.0 (referent) 1.0 (referent) 1.0 (referent) 2.32 (1.50, 3.58) 14.3 (9.72, 21.0) <0.001
Atherosclerosis Risk in
Communities Study
Range of predicted riska,b 0.02–2.9 3.0–5.9 6.0–11.1 11.2–23.4 23.5–102.0
Probabilityc, % 0.8 2.1 3.6 8.3 29.1 <0.001
HR (95% CI) 1.0 (referent) 2.75 (1.14, 6.61) 5.18 (2.24, 12.0) 13.5 (5.91, 30.7) 64.5 (26.7, 156) <0.001
San Antonio Heart Study
Range of predicted riska,b 0.02–5.9 6.0–12.2 12.3–22.6 22.7–44.3 44.4–128.1
Probabilityc, % 1.0 1.9 3.8 8.1 29.1 <0.001
HR (95% CI) 1.0 (referent) 1.98 (0.86, 4.46) 4.35 (2.01, 9.43) 10.5 (4.91, 22.4) 51.4 (22.8, 116) <0.001
Abbreviations: CI, confidence interval; HR, hazard ratio.
a The bottom 3 quintiles of risk in the FraminghamOffspring Study are equivalent because of the constraints of the point scoring system, in which
all persons with a point score of 10 or less are assigned a 3% risk over a period of 8 years (which is converted to 4 cases per 1,000 person-
years). The top quintile is also constrained by a maximum possible risk of 35% over 8 years for any score of 25 or more.
b Per 1,000 person-years.
c Probability of developing diabetes over a period of 4.75 years (the median length of follow-up available for analysis).
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prediction models demonstrated good estimation of diabetes
risk (Hosmer-Lemeshow goodness-of-fit test: P > 0.10). In
addition, using the best-fit model, the predicted incidence
rates of diabetes were not statistically significantly different
from the observed rates of diabetes, indicating a good model
fit for each prediction model (Hosmer-Lemeshow goodness-
of-fit test: P > 0.10).
DISCUSSION
In the current study, each of 3 previously published di-
abetes risk prediction models maintained high levels of dis-
criminative validity when applied in a contemporary,
multiethnic cohort of US adults. The growing epidemic of
diabetes makes this ability to identify persons at high risk
critically important. Over the past 2 decades, the prevalence
of diabetes risk factors such as obesity has increased sub-
stantially (19). Obesity among US adults increased from
13% to 32% between the 1960s and 2004, with 41% pre-
dicted to be obese by 2015 (20). It is reassuring that the
ability to differentiate relative levels of diabetes risk using
these prediction models has not been mitigated by the in-
creasing prevalence of risk factors. The high levels of dis-
criminative ability also support the use of these models
among multiethnic populations for identifying subgroups
at high risk of diabetes.
While the discriminative ability of impaired fasting glu-
cose was higher than that of all of the other individual risk
factors, it did not predict diabetes as well as the risk pre-
diction models. In fact, no single risk factor was as powerful
as the full prediction models for discriminating the risk of
incident diabetes. This highlights the utility of risk models
above estimation based on any single risk factor alone. It
also illustrates that readily available data on clinical risk
factors can be combined to target high-risk adults for di-
abetes prevention interventions.
While the Framingham model using a point scoring sys-
tem performed well, its predictive ability, as judged by the c
statistic, was significantly inferior to that of the ARIC and
San Antonio risk prediction models. However, we remedied
this difference by using a logistic equation model rather than
the point scoring system. This indicates that the grouping of
low- and high-risk participants into single risk estimation
categories (3% and >35%, respectively) and the use of
dichotomous predictors led to a small decrement in discrim-
inative ability. This is balanced by the enhanced potential of
the point scoring system in current clinical practice.
Although a core set of variables, including fasting glu-
cose, HDL cholesterol, blood pressure, family history, and
a measure of adiposity (either body mass index or waist
circumference), are common to all 3 equations evaluated
in the current study, each prediction model has variations
in its components. For example, the ARIC equation includes
black race as a variable, while the San Antonio equation
includes Mexican ethnicity. The San Antonio equation is
Figure 1. Observed, predicted, recalibrated, and best-fit probabili-
ties of incident diabetes (%) over a 4.75-year period by quintile of
predicted risk, calculated using risk prediction equations from A) the
Framingham Offspring Study, B) the Atherosclerosis Risk in Commu-
nities Study, and C) the San Antonio Heart Study.
Table 4. C Statistics for Prediction of Incident Diabetes in the Multi-Ethnic Study of Atherosclerosis Using Risk Prediction Equations From the
Framingham Offspring Study, the Atherosclerosis Risk in Communities Study, and the San Antonio Heart Study, Overall and By Race/Ethnicity
Risk Prediction Model
Total Whites African Americans Hispanics Chinese Americans
C 95% CI C 95% CI C 95% CI C 95% CI C 95% CI
Framingham Offspring Study 0.78 0.74, 0.82 0.80 0.72, 0.87 0.78 0.70, 0.85 0.75 0.72, 0.78 0.78 0.65, 0.90
Atherosclerosis Risk in
Communities Study
0.84 0.82, 0.86 0.86 0.82, 0.90 0.81 0.77, 0.85 0.82 0.78, 0.86 0.83 0.77, 0.89
San Antonio Heart Study 0.83 0.81, 0.85 0.85 0.81, 0.89 0.80 0.76, 0.84* 0.81 0.77, 0.85 0.85 0.79, 0.90
Abbreviation: CI, confidence interval.
* P < 0.05 (African Americans vs. whites).
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also unique in its inclusion of age and sex, while the ARIC
equation is the only one to include waist circumference
rather than body mass index. Despite variations in the in-
clusion of variables, each of the risk models provided sim-
ilar c statistics. This suggests that the core set of risk
prediction variables is stable in terms of the variables’ dis-
criminative ability, regardless of small alterations in the
relative importance of each individual predictor between
risk equations.
When individual ethnic groups in MESA were analyzed
separately, there were only small differences in the discrim-
inative abilities of the risk prediction models. The continued
ability of prediction models derived from mono- and bieth-
nic cohorts to discriminate levels of risk in a multiethnic
population that included Chinese Americans as well as ad-
ditional Hispanic groups beyond Mexicans provides evi-
dence for their applicability in the increasingly diverse US
population.
The ARIC prediction model maintained good calibra-
tion in the bottom 4 quintiles but underestimated diabetes
risk in the highest quintile, while the Framingham and San
Antonio models systematically under- or overestimated the
observed rates of incident diabetes in MESA. Recalibra-
tion remedied this issue for all 3 models, with a more dra-
matic effect in the highest quintile, as this group had the
largest disparity between observed and predicted rates in
all 3 models. The need for recalibration is not surprising
given the differences in the sample characteristics (time,
race/ethnicity, diabetes incidence, etc.) between MESA
and the prior cohorts. Using the best-fit models, the
predicted rates of diabetes incidence were markedly simi-
lar to the observed rates in MESA for each prediction
model. The accuracy of the recalibrated and best-fit models
suggests that the participant characteristics included in the
diabetes risk prediction models have retained their impor-
tance in a contemporary, multiethnic cohort, but the
underlying incidence of diabetes and the relative impor-
tance of each risk factor may have changed over time from
those used in the derivation cohorts. Therefore, without
recalibration, the ability of these equations to generate an
accurate point estimate of an individual’s diabetes risk may
be inadequate.
The current study had both strengths and limitations. Its
strengths included the large, ethnically diverse population,
the detailed clinical and metabolic characterization of the
cohort, and active follow-up for incident diabetes. MESA
is remarkable for its ability to provide in-depth data on
sociodemographic, physiologic, and medical characteris-
tics that reflect an ethnically diverse population. Limita-
tions included the inability to isolate persons of Mexican
ethnicity in MESA in order to match the San Antonio
equation; the shorter follow-up time in MESA as compared
with the studies in which the diabetes risk prediction
models were developed; and the lack of oral glucose tol-
erance testing results in MESA, which were used as part of
the definition of diabetes in the other cohort studies. In
addition, analyses comparing the observed incidence of
diabetes with the predicted incidence of diabetes used
quintiles rather than deciles, since there were only 446
cases of incident diabetes.
The maximum age at the baseline MESA examination
was higher (84 years) than that of the populations included
when the risk models were developed (e.g., the maximum
age in ARIC was 64 years), and MESA, by design, included
a more racially/ethnically diverse population. While this
was a major strength of MESA that allowed us to test the
performance characteristics of the previous models in a con-
temporary cohort, it was also a limitation, since these same
characteristics (e.g., Chinese ethnicity) were often not ac-
counted for in the original models and their impact on val-
idity could not be fully explored. The mean follow-up in
MESA was 4.5 years as compared with 7.5–9 years in the
previous models. As Hippisley-Cox and Coupland noted
previously (21), the importance of each risk factor may vary
over time, and the differential follow-up may explain some
of the calibration issues between the previous models and
MESA.
Diabetes risk prediction models derived from single or
biethnic cohorts, including those from the Framingham Off-
spring Study, the ARIC Study, and the San Antonio Heart
Study, maintained high levels of discriminative ability when
applied to a modern, multiethnic cohort. However, the cal-
ibration of these models was not adequate, requiring recali-
bration to avoid significant over- or underestimation of the
observed diabetes risks. Clinicians should be encouraged to
use these diabetes risk prediction models to stratify their
patient populations. However, recalibration is needed before
these equations can be used to estimate the risk of diabetes
for individual patients.
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Framingham Offspring Study point scoring model
As per the original model development paper (7), the
Framingham point scoring system was recreated using the
following dichotomous risk factors: 10 points for a fasting
glucose level of 100–125 mg/dL, 2 points for a body mass
index (weight (kg)/height (m)2) of 25–29.9, 5 points for
a body mass index of 30, 5 points for a high density
lipoprotein (HDL) cholesterol level of <40 mg/dL in men
or <50 mg/dL in women, 3 points for a parental history of
diabetes, 3 points for a triglyceride level of 150 mg/dL,
and 1 point for elevated blood pressure (systolic blood pres-
sure 130 mm Hg or diastolic blood pressure 85 mm Hg
or use of antihypertensive medication). Points were summed
for each participant, and the risk of diabetes over 8 years
was calculated as shown in Appendix Table 1.
Appendix Table 1. Point scoring system used for predicting
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Framingham Offspring Study logistic regression model
X ¼ 5.517 þ 1.983 (1 if impaired fasting glucose, else
0) þ 0.30 3 (1 if overweight, else 0) þ 0.92 3 (1 if obese,
else 0)þ 0.943 (1 if low HDL cholesterol, else 0)þ 0.583
(1 if high triglycerides, else 0)þ 0.503 (1 if elevated blood
pressure, else 0) þ 0.57 3 (1 if family history of diabetes,
else 0).
Best-fit Multi-Ethnic Study of Atherosclerosis (MESA)/
Framingham logistic regression model
X ¼ 4.281 þ 2.26 3 (1 if impaired fasting glucose,
else 0) þ 0.157 3 (1 if overweight, else 0) þ 0.189 3 (1 if
obese, else 0)þ 0.0633 (1 if low HDL cholesterol, else 0) þ
0.0823 (1 if high triglycerides, else 0)þ 0.1573 (1 if elevated
blood pressure, else 0) þ 0.211 3 (1 if family history of
diabetes, else 0).
Atherosclerosis Risk in Communities (ARIC) Study
logistic regression model
X ¼ 9.9808 þ 0.0173 3 age in years þ 0.4433 3 if
blackþ 0.49813 1 if family history of diabetes is presentþ
0.0880 3 fasting glucose in mg/dL þ 0.0111 3 systolic
blood pressure in mm Hg þ 0.0273 3 waist circumference
in cm  0.0326 3 height in cm  0.0122 3 HDL choles-
terol in mg/dL þ 0.00271 3 triglycerides in mg/dL.
Best-fit MESA/ARIC logistic regression model
X¼12.911 0.3053 age in yearsþ 0.1813 if blackþ
0.578 3 1 if family history of diabetes is present þ 0.119 3
fasting glucose in mg/dLþ 0.0063 systolic blood pressure in
mm Hg þ 0.028 3 waist circumference in cm  0.015 3
height in cm 0.0093HDL cholesterol in mg/dLþ 0.0013
triglycerides in mg/dL.
San Antonio Heart Study regression model
X ¼ 13.415 þ 0.0283 age in years þ 0.6613 sex (1 if
female, else 0) þ 0.412 3 1 if Mexican þ 0.079 3 fasting
glucose in mg/dL þ 0.018 3 systolic blood pressure in mm
Hg  0.039 3 HDL cholesterol in mg/dL þ 0.070 3 body
mass indexþ 0.4813 1 if family history of diabetes, else 0.
Best-fit MESA/San Antonio Heart Study regression model
X ¼ 14.836 – 0.239 3 age in years þ 0.367 3 sex (1 if
female, else 0) – 0.129 3 1 if Mexican þ 0.122 3 fasting
glucose in mg/dL þ 0.006 3 systolic blood pressure in mm
Hg  0.016 3 HDL cholesterol in mg/dL þ 0.034 3 body
mass indexþ 0.5673 1 if family history of diabetes, else 0.
The probability of developing diabetes was calculated as
exp(X)/(1 þ exp(X)).
Once the probability of diabetes was calculated, it was
adjusted to represent 4.75 years of follow-up by dividing the
probability by duration of follow-up in each of the prior
cohorts (8, 9, and 7.5 years for Framingham, ARIC, and
San Antonio, respectively) and multiplying this fraction
by 4.75.
Appendix Table 2. Probabilitya (%) of Incident Diabetes in the
Multi-Ethnic Study of Atherosclerosis According to Quintile of
Predicted Risk, Determined Using Risk Prediction Equations From
the Framingham Offspring Study, the Atherosclerosis Risk in
Communities Study, and the San Antonio Heart Study
Risk Prediction Model
Quintile of Predicted Risk
1 2 3 4 5
Framingham Offspring Study
Observed 3.2 3.2 3.2 6.6 27.5
Predicted 1.8 1.8 1.8 2.6 9.3
Recalibrated 2.8 2.8 2.8 9.0 27.7
Best-fit 3.2 3.2 3.2 7.4 27.1
Atherosclerosis Risk in
Communities Study
Observed 0.8 2.1 3.5 8.0 27.5
Predicted 0.8 2.1 3.9 7.8 21.8
Recalibrated 0.8 2.0 3.8 7.8 27.6
Best-fit 0.8 2.0 3.7 7.3 28.1
San Antonio Heart Study
Observed 1.0 1.9 3.7 7.7 27.6
Predicted 1.6 4.2 8.1 15.3 34.8
Recalibrated 0.7 1.8 3.8 7.9 27.6
Best-fit 1.0 2.1 4.0 7.3 27.5
a Probability of developing diabetes over a period of 4.75 years.
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